Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

TY - JOUR

T1 - Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies

T2 - Determining demographic differences in the USA

AU - Go, Ronald S.

AU - Heien, Herbert C.

AU - Sangaralingham, Lindsey R.

AU - Habermann, Elizabeth B.

AU - Shah, Nilay D.

N1 - Funding Information: 1Division of Hematology and 2Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA Funding: this study was supported by research funding from the Mayo Clinic Division of Hematology to RSG, Mark A. and Elizabeth N. Binks Fund to RSG, and from the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to RSG. Correspondence: go.ronald@mayo.edu doi:10.3324/haematol.2017.179978 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042754535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042754535&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.179978

DO - 10.3324/haematol.2017.179978

M3 - Letter

C2 - 29269527

AN - SCOPUS:85042754535

VL - 103

SP - e123-e125

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -